CLINICAL AND SUBCLINICAL CHARACTERISTICS AND FACTORS ASSOCIATED WITH LOW BONE MINERAL DENSITY IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS AT VIET TIEP FRIENDSHIP HOSPITAL

Do Thi Thanh Loan1, Nguyen Ngoc Anh1, Trinh Hong Nhung1
1 Haiphong University of Medicine and Pharmacy

Main Article Content

Abstract

Objective: To describe the clinical and subclinical characteristics and to identify factors associated with low bone mineral density (BMD) in transfusion-dependent thalassemia (TDT) patients at the department of Clinical Hematology, Viet Tiep Friendship hospital.


Methods: A cross-sectional descriptive study was conducted. Clinical data, laboratory tests, and BMD measured by DEXA were collected for all patients. Low BMD was defined as a Z-score < -2.0, and its association with patient characteristics was analyzed.


Results: The prevalence of low BMD was 45.1%, with a median Z-score of -2.2 (-4.5 – 1.1). Mean hemoglobin was 76.3 ± 9.7 g/L, with most patients having moderate to severe anemia (92.2%). Median ferritin was 2322.9 (438.5–7545.0) ng/mL, with 82.3% of patients having ferritin > 1000 ng/mL. Factors significantly associated with low BMD included disease severity (p < 0.05), poor adherence to iron chelation therapy (92.9% vs. 69.6%; p < 0.05), lower hemoglobin (72.3 ± 9.9 vs. 80.9 ± 7.6 g/L), higher serum iron (34.5 vs. 26.3 µmol/L), and higher ferritin (2775.0 vs. 1394.0 ng/mL).


Conclusion: Low BMD is a common complication in TDT patients, associated with disease severity, chronic anemia, iron overload, and poor adherence to iron chelation therapy.

Article Details

References

1. Thalassaemia International Federation (2021). Guidelines for the management of transfusion dependent thalassaemia (TDT). 4th ed. Nicosia: Thalassaemia International Federation.
2. Cappellini MD, Farmakis D, Porter J, Taher A, Aydinok Y, et al. (2021). Guidelines for the management of transfusion dependent thalassaemia (TDT). 4th ed.3.
3. Taher AT, Musallam KM, Cappellini MD (2021). Thalassemia. The Lancet, 397(10291), 373–383.
4. De Sanctis V, Soliman AT, Elsedfy H, et al. (2016). Osteoporosis in thalassemia major: an update. Clinical Cases in Mineral and Bone Metabolism, 13(3), 187–192.
5. Voskaridou E, Terpos E (2004). New insights into the pathophysiology and management of osteoporosis in patients with thalassemia. British Journal of Haematology, 127(2), 127–139.
6. Bộ Y tế (2022). Hướng dẫn chẩn đoán và điều trị bệnh Thalassemia. Hà Nội: Nhà xuất bản Y học.
7. International Society for Clinical Densitometry (2019). Official Positions of the International Society for Clinical Densitometry.